Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients
Figure 4.Functions and signaling mechanisms involved in KLRB1. (A) BP; (B) MF; (C) CC; (D) KEGG.